The biotechnology company Bio-Works receives approximately SEK 0.4 million before issue costs after 403,058 warrants of series TO 2 were exercised, according to a press release.The number of shares increases to approximately 100.4 million and the dilution amounts to about 0.4 percent. The next exercise period runs from October 1 to 14, 2026.